Focus Review - The robotics sector sees strong entry from industrial capital, with Astribot completing hundreds of millions in A++ round financing led by Guoke Investment and Ant Group, alongside other notable investors [4][14] - The health sector, particularly gene and cell therapy (CGT), remains hot, with Zhonghe Gene completing tens of millions in Pre-A+ round financing, and Ruipu Morning achieving 500 million in A+ round financing [4][31] - AI and data are in high demand, with Guanglun Intelligent announcing several hundred million in A and A+ round financing, and DataArc completing seed rounds totaling tens of millions [5][41] New Consumption - L'Oréal invests in Chinese skincare brand LAN, marking its first investment in a local skincare brand [7] - Lingyu Universe secures 200 million in Pre-A round financing from major financial institutions [8] Hard Technology - Bosi Xinyu completes several million in angel+ round financing led by Zhongguancun Development Group [11] - Ganfeng Technology announces a strategic investment of 100 million from Meihua Venture [12] - Huanxi Intelligent completes its second round of financing within a year, backed by Shunyu Capital [13] Health Sector - Anxin Medical completes tens of millions in angel round financing led by Haiyuan Capital [22] - SenseTime Medical secures hundreds of millions in Pre-A+ round financing from various investors [24] - Mingche Technology announces tens of millions in A round financing [25] Internet/Enterprise Services - Yisixuan Magnetic completes seed round financing of several million [36] - Bili Information secures tens of millions in A+ round financing from Tiantu Investment [37] - Boundary Consulting receives over 400 million in strategic investment from Huaitongda Network [38]

Group 1 - Nanjing Yuanmai Cell Biotechnology Co., Ltd. has successfully received joint investment from the Nanjing University Technology Achievement Transformation Angel Fund and the Future Industry Angel Fund, marking the official launch of the Nanjing University Technology Achievement Transformation Angel Fund established in March this year [1] - Yuanmai Cell, founded in September 2022, focuses on the research and development of cell immunotherapy drugs, leveraging four core technology platforms: CAR-T module design, sequence screening, efficient gene delivery, and iPSC differentiation [1] - The founder, Professor Shen Pingping, is recognized as a leading authority in macrophage research and has received multiple funding supports from national and provincial programs, enhancing the company's research capabilities [1] Group 2 - The investment reflects the critical role of government-guided funds in accelerating the transformation of university scientific achievements into productive forces, thereby enhancing Nanjing's influence in the gene and cell therapy industry [2] - The Nanjing University Technology Achievement Transformation Angel Fund has a total scale of 500 million yuan, marking it as the first university technology achievement transformation fund in Jiangsu Province's strategic emerging industry special fund [2] - The fund aims to address the "last mile" challenge in transforming university scientific achievements into tangible productivity, with a focus on supporting projects in the biomedical and information communication sectors [3]